Neuropsychopharmacology
- Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci2 years ago
- Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam2 years ago
- Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks2 years ago
- Dorsal raphe to basolateral amygdala corticotropin-releasing factor circuit regulates cocaine-memory reconsolidation2 years ago
- Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial2 years ago
- A neural pathway integrating stress and feeding2 years ago
- Placebo response in RCT for antidepressant may not always be the ‘villain’ to fight: are KOR antagonists possibly affecting the intrinsic placebo response?2 years ago
Journal of Psychopharmacology
- Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans5 years ago
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study5 years ago
- Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA5 years ago
- Prospective memory deficits following acute alcohol consumption5 years ago
- Altered amygdala-cortical connectivity in individuals with Cannabis use disorder5 years ago
- Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series5 years ago
- Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro5 years ago
European Neuropsychopharmacology
- Social Stress in Bipolar Disorder4 years ago
- Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology4 years ago
- Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)4 years ago
- Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial4 years ago
- The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations4 years ago
- Depression, antidepressants, and insulin resistance: which link?4 years ago
- Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study4 years ago